167 related articles for article (PubMed ID: 2447664)
21. The effect of exercise on bleeding time and local production of prostacyclin and thromboxane.
Carter JW; Ready AE; Singhroy S; Duta E; Gerrard JM
Eur J Appl Physiol Occup Physiol; 1989; 59(5):355-9. PubMed ID: 2513183
[TBL] [Abstract][Full Text] [Related]
22. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
Pedvis LG; Wong T; Frojmovic MM
Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
[TBL] [Abstract][Full Text] [Related]
23. Altered sensitivity to prostacyclin may be involved in the exercise-induced activation of platelets in patients with ischemic heart disease.
Kishi Y; Numano F; Oniki T; Yajima M; Numano F
Prog Clin Biol Res; 1989; 301():181-5. PubMed ID: 2508101
[No Abstract] [Full Text] [Related]
24. Influence of iloprost on eicosanoid generation and lipid levels in experimental myocardial ischemia in dogs.
Beitz A; Taube C; Beitz J; Goos H; Graff J; Nöhring J; Lindenau KF; Mest HJ
Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):141-5. PubMed ID: 2469084
[TBL] [Abstract][Full Text] [Related]
25. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF
Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296
[TBL] [Abstract][Full Text] [Related]
26. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
Ylikorkala O; Mäkilä UM; Viinikka L
Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
[TBL] [Abstract][Full Text] [Related]
27. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
[TBL] [Abstract][Full Text] [Related]
28. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
Cowley AJ; Heptinstall S; Hampton JR
Thromb Haemost; 1985 Feb; 53(1):90-4. PubMed ID: 2581332
[TBL] [Abstract][Full Text] [Related]
29. Platelet hyperaggregability occurring during prolonged continuous intravenous infusions of prostacyclin analogue ZK 36374.
Yardumian DA; Mackie IJ; Bull H; Goldstone AH; Machin SJ
Br J Haematol; 1985 May; 60(1):109-16. PubMed ID: 2408653
[TBL] [Abstract][Full Text] [Related]
30. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion.
Chiariello M; Golino P; Cappelli-Bigazzi M; Ambrosio G; Tritto I; Salvatore M
Am Heart J; 1988 Mar; 115(3):499-504. PubMed ID: 2449815
[TBL] [Abstract][Full Text] [Related]
31. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation.
Addonizio VP; Fisher CA; Jenkin BK; Strauss JF; Musial JF; Edmunds LH
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):926-33. PubMed ID: 2582210
[TBL] [Abstract][Full Text] [Related]
32. Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function.
Yardumian DA; O'Flynn K; Linch DC; Machin SJ
Br J Haematol; 1987 Mar; 65(3):325-30. PubMed ID: 2436647
[TBL] [Abstract][Full Text] [Related]
33. [Newly developed stenocardia: functional activity of thrombocytes].
Shalaev SV; Panchenko EP; Masenko VP; Smirnov IE; Vinogradova IV
Kardiologiia; 1988 Jul; 28(7):63-8. PubMed ID: 2974904
[TBL] [Abstract][Full Text] [Related]
34. The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZB/W F1 mouse.
Clark WF; Parbtani A; McDonald JW; Taylor N; Reid BD; Kreeft J
Clin Nephrol; 1987 Dec; 28(6):288-94. PubMed ID: 2450713
[TBL] [Abstract][Full Text] [Related]
35. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.
Elias M; Heethuis A; Weggemans M; Bom V; Blom N; McShine RL; Halie MR; Smit Sibinga CT
Ann Hematol; 1992 Jun; 64(6):292-8. PubMed ID: 1379080
[TBL] [Abstract][Full Text] [Related]
36. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226
[No Abstract] [Full Text] [Related]
37. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
38. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
39. Effects of the platelet inhibitor ticlopidine on exercise tolerance in stable angina pectoris.
Berglund U; Lassvik C; Wallentin L
Eur Heart J; 1987 Jan; 8(1):25-30. PubMed ID: 2949974
[TBL] [Abstract][Full Text] [Related]
40. [Unstable stenocardia: functional activity and free cytoplasmic calcium of thrombocytes and vaso- and thrombocytoactive prostanoids].
Panchenko EP; Shalaev SV; Gratsianskiĭ NA; Giorgadze ML; Popov IuM
Kardiologiia; 1987 Oct; 27(10):27-32. PubMed ID: 3695081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
